What is Astera Labs' business?
Astera Labs designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure.
Yanuki
ARTICLE DETAIL
Astera Labs Attracts and Loses Institutional Investor Interest | Stock Market Futures Fall, Oil Slides After Volatile Day | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Astera Labs Attracts and Loses Institutional Investor Interest | Stock Market Futures Fall, Oil Slides After Volatile Day | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives
Finance / Stocks
Astera Labs Attracts and Loses Institutional Investor Interest
Astera Labs, Inc. (NASDAQ:ALAB) has seen notable activity from institutional investors recently. Several firms have adjusted their stakes in the company, reflecting varying perspectives on its potential. This article summarizes these change...
Key Insights
- Principal Financial Group Inc. reduced its holdings by 44.6% during Q1 2025.
- Morse Asset Management Inc lowered its stake by 10.3% in Q1 2025.
- TimesSquare Capital Management LLC trimmed its holdings by 87.2% in Q1 2025.
- Several firms, including Whittier Trust Co. of Nevada Inc., Murphy & Mullick Capital Management Corp, Sound Income Strategies LLC, GAMMA Investing LLC, NewEdge Advisors LLC, HighTower Advisors LLC, Commonwealth Equity Services LLC, Natixis Advisors LLC, Envestnet Portfolio Solutions Inc., Thrivent Financial for Lutherans, Steward Partners Investment Advisory LLC, Hoey Investments Inc., and Allworth Financial LP acquired new positions or increased their stakes during Q4 2024 and Q1 2025.
- Insiders have sold 1,965,984 shares of company stock valued at $178,631,873 in the last ninety days.
- Wall Street analysts have a consensus rating of "Moderate Buy" with an average price target of $100.71.
In-Depth Analysis
Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Recent SEC filings reveal shifts in institutional ownership, with some firms reducing their positions while others initiated or increased their stakes.
**Institutional Investor Activity:**
- **Decreased Positions:** Principal Financial Group Inc., Morse Asset Management Inc, and TimesSquare Capital Management LLC reduced their holdings in Q1 2025.
- **Increased Positions:** Several other firms increased their positions or initiated new stakes during the same period. This mixed activity suggests differing opinions on the company's short-term prospects.
**Insider Transactions:**
- Recent insider sales, including those by Director Bethany Mayer, COO Sanjay Gajendra, Director Manuel Alba, CFO Michael Truett Tate, and CEO Jitendra Mohan, indicate a decrease in insider ownership.
**Analyst Ratings:**
- Wall Street analysts have a consensus rating of "Moderate Buy" for Astera Labs, with an average price target of $100.71. However, there have been some recent downgrades, such as Wall Street Zen cutting the rating from "buy" to "hold". Other firms like Needham & Company LLC decreased their price objective, while Evercore ISI lifted their target price. Barclays raised their price objective from $70.00 to $75.00, giving the stock an "overweight" rating in a research note on Wednesday, May 7th&ref=yanuki.com. William Blair initiated coverage on Astera Labs in a research note on Thursday, May 22nd&ref=yanuki.com. They set an "outperform" rating on the stock. Susquehanna initiated coverage on Astera Labs in a research note on Friday, May 16th&ref=yanuki.com. They set a "neutral" rating and a $80.00 price objective on the stock. Finally, Roth Capital set a $100.00 price objective on Astera Labs and gave the stock a "buy" rating in a research note on Wednesday, May 7th&ref=yanuki.com.
**Stock Performance:**
- Astera Labs' stock has experienced volatility, with a 52-week low of $36.22 and a 52-week high of $147.39.
- The stock opened at $102.13 on Monday.
- The business has a 50 day moving average of $92.81 and a two-hundred day moving average of $86.33.
Astera Labs is an AI infrastructure play with significant growth ahead. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.05. The business had revenue of $159.44 million during the quarter, compared to the consensus estimate of $151.55 million. Astera Labs had a return on equity of 2.57% and a net margin of 8.44%. The business's revenue was up 144.1% on a year-over-year basis.
FAQ
What is the analyst consensus rating for Astera Labs?
The consensus rating is "Moderate Buy" with an average price target of $100.71.
Has there been insider selling activity recently?
Yes, insiders have sold a significant number of shares in the last three months.
Takeaways
- Institutional investor activity in Astera Labs is mixed, with some firms increasing their stakes while others reduced theirs.
- Insider selling activity has been notable, indicating a potential lack of confidence among company executives.
- Analysts have a generally positive outlook on the stock, but there have been some recent downgrades.
- Astera Labs operates in the growing AI infrastructure market, which could drive future growth.
Discussion
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.